This man is revolutionizing our understanding of motor neuron diseases and dementias

(Case Western Reserve University) Wang's team published a study in the January 2017 issue of Molecular Therapy that is seen as confirming the relevance of this neurotoxic pathway, according to an accompanying editorial by Eloise Hudry, Ph.D., of the Alzheimer's Disease Research Unit at Harvard Medical School. This paper also confirms TDP-43 inhibition as a viable therapeutic option for the treatment of neurologic disorders, including Alzheimer disease.

https://www.eurekalert.org/pub_releases/2017-01/cwru-tmi012317.php

Source: EurekAlert! - Medicine and Health - January 23, 2017 Category: Global & Universal Source Type: news